Clustering of peptidoglycan recognition protein-SA is required for sensing lysine-type peptidoglycan in insects by Park, JW et al.
Clustering of peptidoglycan recognition protein-SA
is required for sensing lysine-type
peptidoglycan in insects
Ji-Won Park*, Chan-Hee Kim*, Jung-Hyun Kim*, Byung-Rok Je*, Kyung-Baeg Roh*, Su-Jin Kim*, Hyeon-Hwa Lee*,
Ji-Hwan Ryu†, Jae-Hong Lim‡, Byung-Ha Oh‡, Won-Jae Lee†, Nam-Chul Ha*, and Bok-Luel Lee*§
*National Research Laboratory of Defense Proteins, College of Pharmacy, Pusan National University, Busan 609-735, Korea; †Division of Molecular Life
Science, Ewha Woman’s University, Seoul 120-750, Korea; and ‡Division of Molecular and Life Sciences, Department of Life Sciences, Center for
Biomolecular Recognition, Pohang University of Science and Technology, Pohang, Gyeongbuk 790-784, Korea
Edited by Russell F. Doolittle, University of California at San Diego, La Jolla, CA, and approved March 2, 2007 (received for review December 13, 2006)
Recognition of lysine-type peptidoglycan by peptidoglycan recog-
nition protein (PGRP)-SA provokes the activation of the Toll and
prophenoloxidase pathways. Here we reveal that a soluble frag-
ment of lysine-type peptidoglycan, a long glycan chain with short
stem peptides, is a potent activator of the Drosophila Toll pathway
and the prophenoloxidase activation cascade in the beetle
Tenebrio molitor. Using this peptidoglycan fragment, we present
biochemical evidence that clustering of PGRP-SA molecules on the
peptidoglycan is required for the activation of the prophenoloxi-
dase cascade. We subsequently highlight that the lysozyme-
mediated partial digestion of highly cross-linked lysine-type
peptidoglycan dramatically increases the binding of PGRP-SA,
presumably by inducing clustering of PGRP-SA, which then recruits
the Gram-negative bacteria-binding protein 1 homologue and a
modular serine protease containing low-density lipoprotein and
complement control protein domains. The crucial role of lysozyme
in the prophenoloxidase activation cascade is further confirmed in
vivo by using a lysozyme inhibitor. Taken together, we propose a
model whereby lysozyme presents a processed form of lysine-type
peptidoglycan for clustering of PGRP-SA that recruits Gram-nega-
tive bacteria-binding protein 1 and the modular serine protease,
which leads to the activation of both the Toll and prophenoloxi-
dase pathways.
innate immunity  pattern  prophenoloxidase  Toll
Insects rely entirely on innate immunity for defense againstmicrobial pathogens. These defenses include both the induc-
ible expression of antimicrobial peptides and the activation of
prophenoloxidase cascades in hemolymph (insect blood) (1, 2).
For example, Lys-type peptidoglycan (PG) from Gram-positive
bacteria is recognized by the PG recognition protein
(PGRP)-SA or PGRP-SD and thereby activates the Toll signal-
ing pathway and the transcription of antimicrobial peptide genes
(3, 4). This recognition signal is amplified in hemolymph by a
proteolytic cascade similar to the vertebrate complement system.
Drosophila genetic studies have shown that the Gram-negative
bacteria-binding protein 1 (GNBP1), together with PGRP-SA, is
also required to activate the Toll pathway in response to
Gram-positive bacterial infection (5, 6). Diaminopimelic acid-
type PG, usually found in Gram-negative bacteria, induces
innate immune responses inDrosophila by activating the immune
deficiency pathway (7, 8). A naturally occurring monomeric
fragment of diaminopimelic acid-type PG, known as tracheal
cytotoxin, specifically activates the immune deficiency pathway
by inducing heterodimerization of its recognition receptors,
PGRP-LCa and PGRP-LCx (9, 10). In sharp contrast, the Toll
signaling pathway is not induced by muropeptide, a monomeric
fragment of Lys-type PG composed of N-acetylglucosamine and
N-acetylmuramic acid linked with a short peptide chain as a stem
(11), although this muropeptide is the minimum binding unit for
PGRP-SA (12–15).
The prophenoloxidase activation cascade, which leads to
melanization of invading microbes, is another major innate
immune defense mechanism in invertebrates that is triggered by
PG and fungal -1,3-glucan in the hemolymph (16, 17). We
previously identified the Tenebrio PGRP-SA in the beetle
Tenebrio molitor that exhibited the highest sequence homology
with Drosophila PGRP-SA (18). We also reported that Tenebrio
PGRP-SA is essential for the PG-dependent prophenoloxidase
pathway activation and that a synthetic muropeptide dimer,
linked by a -1,4-glycosidic bond between the sugars, functions
as a competitive inhibitor of soluble polymeric Lys-type PG in
the activation of the prophenoloxidase system (18). However, it
has not been known whether GNBP1 or its homologue is
involved in the PG-dependent prophenoloxidase activation
system.
Although insects encode several lysozymes that digest PG,
these enzymes are likely to be involved in the immune response,
but their roles have not yet been clearly delineated (19). Ly-
sozyme present in the hemolymph may function directly as an
antibacterial, or it could be involved in the processing and/or
elimination of PG to modulate the immune response (20).
However, highly cross-linked or modified Lys-type PG would be
resistant to a complete digestion by lysozyme, resulting in a
partially digested PG in bacteria (21). Here we focus on the
biochemical and immunological properties of this partially di-
gested PG. With multiple approaches, using the in vivo Drosoph-
ila Toll pathway, the in vitro prophenoloxidase activation system,
and recombinant PGRP-SA proteins, we show that Lys-type PG
triggers PGRP-SA clusters leading to the activation of the Toll
and prophenoloxidase pathways by recruiting GNBP1 and a
unique modular serine protease.
Results
A Linearized Lys-Type PG Activates both the Toll and Prophenoloxi-
dase Pathways. Achromobacter -lytic protease is a lysostaphin-
like enzyme that hydrolyzes the peptide bonds in the penta-Gly
bridge present in Staphylococcus aureus PG (22). Using -lytic
protease, we solubilized S. aureus Lys-type PG by cleaving the
penta-Gly bridge between the stem peptides, generating a lin-
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earized PG containing a long glycan chain with stem peptides
(Fig. 1A Upper). Because this linearized PG contains many
copies of muropeptide units, it should have multiple binding sites
for PGRP-SA. Using the linearized PG, we confirmed that both
the recombinant Drosophila PGRP-SA and Tenebrio PGRP-SA
proteins bind to the linearized PG using size-exclusion chroma-
tography [supporting information (SI) Fig. 7 B and C]. However,
a mixture of Tenebrio PGRP-SA and the synthetic muropeptide
dimer linked between the sugars (Fig. 1A Lower), which was
previously used (18), showed the same elution profile as Tenebrio
PGRP-SA alone, suggesting that the synthetic muropeptide
dimer can bind to only one molecule of PGRP-SA (SI Fig. 7D).
Consistent with these binding activities, the linearized PG, but
not the synthetic muropeptide dimer, displayed potent immu-
nostimulatory activities. To address these points, we used two
innate immune responses: the well characterized in vivo Dro-
sophila Toll pathway to examine antibacterial peptide expression
and the Tenebrio prophenoloxidase cascade system in the large
beetle to perform biochemical studies in vitro. We found that the
linearized PG consistently induced strong phenoloxidase activity
when the fractionated linearized PG was added to Tenebrio
hemolymph solution (Fig. 1B), indicating that linearized PG can
activate PG-dependent prophenoloxidase cascade. Subse-
quently, we injected the linearized PG into wild-type and
PGRP-SAseml mutant flies and then monitored expression of the
drosomycin-encoding gene to test whether the linearized PG can
activate the Drosophila Toll pathway in vivo (Fig. 1C). Indeed,
the linearized PG-injected wild-type flies induced drosomycin
expression normally, but PGRP-SAseml mutant flies were defec-
tive in the induction of the antimicrobial peptide, demonstrating
that the linearized PG activates the Toll pathway in a PGRP-
SA-dependent manner. In contrast, the synthetic muropeptide
dimer induced only very weak drosomycin expression in the
wild-type flies whereas the PGRP-SAseml mutant flies were
unresponsive (Fig. 1C). Likewise, the linearized PG, but not the
synthetic muropeptide dimer, strongly inducedmelanin synthesis
when injected into the larvae of Tenebrio, most likely by activa-
tion of the prophenoloxidase system (Fig. 1D). These results
suggest that the PG fragment containing multiple binding sites
for PGRP-SA can induce the Toll and prophenoloxidase path-
ways. Recently, Ligoxygakis and his colleagues (11) suggested
that PG should be processed to increase the number of reducing
ends to activate the Toll signaling pathway. Because both the
linearized PG and the synthetic muropeptide dimer contain one
reducing end each but only the linearized PG is able to induce
activation of both Toll and prophenoloxidase cascades, this may
suggest that the reducing ends may not be important.
Clustering of PGRP-SA Is Needed for the Activation of the Prophe-
noloxidase Cascade. We initially attempted to determine the
minimal concentration of the linearized PG for activation of the
PG-dependent prophenoloxidase cascade. The phenoloxidase
activity was measured by incubation of hemolymph with differ-
ent amounts of the linearized PG. Unexpectedly, the phenoloxi-
dase activity was severely inhibited to the baseline level at high
concentrations of the linearized PG, showing a classic bell-
shaped dose–response curve (Fig. 2A). Moreover, the concen-
tration of the linearized PG where the maximum phenoloxidase
activity was produced could be significantly shifted with a
stronger phenoloxidase activity if exogenous Tenebrio PGRP-SA
protein was added to the reaction mixture (Fig. 2A). This shift
in optimal concentration of linearized PG by addition of
Tenebrio PGRP-SA protein suggests that the molar ratio be-
tween PGRP-SA and PG is important in the activation of
prophenoloxidase cascade. These observations imply that too
much linearized PG acts as a competitive inhibitor by seques-
tering PGRP-SA molecules, impairing the initial activating
complex composed of clustered PGRP-SA molecules bound to
one linearized PG molecule (see Fig. 2A Insets). Similar obser-
vations were reported in -1,3-glucan recognition of the horse-
shoe crab factor G and in LPS recognition of the crayfish
prophenoloxidase system (23, 24).
We further investigated the initial activation step for Lys-type
PG recognition using recombinant Drosophila PGRP-SA that is
able to bind the linearized PG with a similar affinity as Tenebrio
PGRP-SA (SI Fig. 7C), but the Drosophila PGRP-SA cannot
induce activation of the Tenebrio prophenoloxidase cascade (Fig.
2B, column 3). The phenoloxidase activity induced by the
Fig. 1. Linearized PG activates theDrosophila Toll pathway and induces Tenebriomelanin syntheses in vivo. (A) Expected structures of the linearized PG (Upper)
and synthetic muropeptide dimer (Lower). Red, green, blue, and yellow balls indicate N-acetyl-glucosamine, N-acetylmuramic acid, stem peptides, and Gly
residues of S. aureus PG, respectively. (B) The UV absorbance profile (black line) of the linearized PG fractionated on a Toyopearl HW-55S size-exclusion column
and the phenoloxidase activity (red line) of each linearized PG fraction were plotted simultaneously. (C) Induction of the drosomycin (Drs)-Rp49 reporter gene
after the injection of water (white), synthetic muropeptide dimer (yellow), or the linearized PG (purple) into wild-type female adult flies and PGRP-SAseml mutant
flies. Drs expression was measured in four flies collected 18 h after challenge and normalized to the value obtained after injection of water (set at 100%). Bars
represent the mean SD of four independent experiments. (D) One hundred nanograms of the synthetic muropeptide dimer (Left) or the linearized PG (Right)
was injected into Tenebrio larvae. Within 18 h, appearance of melanin pigment was examined.








linearized PG was severely inhibited by the addition of Drosoph-
ila PGRP-SA to the hemolymph solution even in the presence of
exogenous Tenebrio PGRP-SA (Fig. 2B, column 4). This implies
that the initial activating complex in the prophenoloxidase
cascade is abolished by replacement of a part of Tenebrio
PGRP-SA molecules by Drosophila PGRP-SA on the linearized
PG. These results strongly suggest again that clustering of
Tenebrio PGRP-SA on Lys-type PG is required for the initial
activation of prophenoloxidase cascade.
Lys-Type PG Fragments That Accommodate at Least Two Tenebrio
PGRP-SA Molecules Activate the Prophenoloxidase System. To de-
termine how many molecules of Tenebrio PGRP-SA constitute
the initial activating complex for the prophenoloxidase system,
the various lengths of sugar chains of PG were generated by
partial digestion of the linearized PG with lysozyme and were
then fractionated according to their length on a size-exclusion
column (Fig. 3A Upper and Lower). Three fractions (the 7th,
10th, and 14th fractions) showed the phenoloxidase activity
when each fraction was incubated with the Tenebrio PGRP-SA-
depleted hemolymph solution in the presence of the Tenebrio
PGRP-SA protein and Ca2. Of these, among the PG fragments
in fraction 14 should be a smallest unit that is able to induce
activation of the prophenoloxidase cascade. After adding an
excess amount of Tenebrio PGRP-SA protein, we analyzed how
many PGRP-SA molecules can bind to the PG fragment in
fraction 14 by monitoring the apparent molecular mass on a
size-exclusion column (Fig. 3B Upper). The apparent molecular
mass of the complex between the PG fragments in the fraction
and Tenebrio PGRP-SA was determined as 40 kDa, which
indicates that the PG fragment binds to two molecules of
PGRP-SA. When the PG fragment/Tenebrio PGRP-SA com-
plex, isolated from this second sizing column, was incubated with
the Tenebrio PGRP-SA-depleted hemolymph solution, it in-
duced phenoloxidase activity even without adding Tenebrio
PGRP-SA, clearly demonstrating that two molecules of
PGRP-SA are sufficient to induce this activity (red line in Fig.
3B Upper). However, muropeptide monomer that was generated
by a prolonged incubation of the linearized PGwith lysozyme did
not change the molecular mass of Tenebrio PGRP-SA protein on
the size-exclusion column and did not activate the prophenoloxi-
dase pathway (Fig. 3B Lower). The synthetic muropeptide dimer
also showed the same pattern (data not shown). This observation
indicates that the synthetic muropeptide dimer and the mu-
Fig. 2. Clustered Tenebrio PGRP-SA is required for prophenoloxidase activation. (A) Lys-type PG-dependent phenoloxidase activity was measured with 10 nM
Tenebrio PGRP-SA (0.2 gml1) and different amounts of the linearized PG (squares). The bell-shaped dose–response curve was shifted to the right by the
addition of Tenebrio PGRP-SA to 120 nM (2.5 gml1), and a maximal point was observed at 100 ng of the linearized PG (circles). Insets indicate the putative
initial complexed structures between Tenebrio PGRP-SA and the linearized PG. R and PG indicate Tenebrio PGRP-SA and linearized Lys-type PG, respectively. (B)
In vitro reconstitution experiments were performed by usingTenebrioPGRP-SA orDrosophilaPGRP-SA with theTenebrioPGRP-SA-deficient hemolymph solution
in the presence of the linearized PG (columns 2 and 3, respectively).TenebrioPGRP-SA andDrosophilaPGRP-SA were coincubated in the presence of the linearized
PG (column 4).
Fig. 3. PG fragments that accommodate two Tenebrio PGRP-SA molecules activate the prophenoloxidase system. (A Upper) The linearized PG only. (A Lower)
Partially digested linearized PG by lysozyme was fractionated by a Toyopearl HW-55S column equilibrated with 20 mM TrisHCl (pH 8.0) containing 150 mM NaCl.
The phenoloxidase activity profile of each fraction is shown in red. (BUpper) A mixture of Tenebrio PGRP-SA with fraction 14 was injected onto the same column.
(B Lower) A mixture of Tenebrio PGRP-SA and the fully digested PG that was fully digested with lysozyme by incubation for 16 h at 37°C was injected onto the
same column.
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ropeptidemonomer can bind to one PGRP-SAmolecule without
inducing phenoloxidase activity as shown in our previous study
(18). It is noteworthy that the synthetic muropeptide dimer binds
to only one PGRP-SA molecule although it contains two copies
of muropeptide. We propose that this is a result of steric
hindrance by the first bound PGRP-SA molecule on the mu-
ropeptide dimer because the two binding units on the synthetic
muropeptide dimer are located too close in this dimeric mole-
cule. However, another muropeptide dimer that is cross-linked
by a penta-Gly bridge might be expected to accommodate two
PGRP-SA molecules because the penta-Gly bridge provides
sufficient space for binding of two PGRP-SA molecules. Con-
sistently, the synthetic muropeptide dimer linked between the
sugars was unable to activate the Toll and prophenoloxidase
pathways as shown above, whereas the muropeptide dimer
cross-linked by a penta-Gly bridge was reported to induce
activation of the Toll pathway (11). Thus, it can be concluded
that the PG fragment that accommodates two PGRP-SA mol-
ecules is the minimum unit that could induce the downstream
events and result in activation of the Toll and prophenoloxidase
pathways.
Lysozyme Presents a Processed Form of PG for PG Recognition Signals.
Most natural Gram-positive bacterial Lys-type PG is highly
cross-linked between the glycan chains, which is different from
that of the linearized PG. We anticipated that PGRP-SA might
have limited access to natural Lys-type PGs because of the highly
cross-linked structure of PG. Moreover, we previously observed
that insoluble Lys-type PGs that were disrupted by sonication
induced a strong phenoloxidase activity in vitro, whereas intact
insoluble Lys-type PGs did not induce prophenoloxidase acti-
vation at a given time (18). To loosen the PG structure by an
enzyme present in insect hemolymph, we chose lysozyme be-
cause it is able to hydrolyze almost all types of intact bacterial PG
(25). We performed partial digestion of Lys-type PG from both
S. aureus and Micrococcus luteus with lysozyme in vitro. Indeed,
the partially digested Lys-type PGs induced a rapid and strong
phenoloxidase activity in the Tenebrio hemolymph in vitro (data
not shown). Moreover, when the partially digested insoluble
Lys-type PGs were injected into Tenebrio larvae, stronger and
faster melanin synthesis was observed in all of the injected larvae
compared with intact insoluble Lys-type PGs (SI Fig. 8 B and C,
respectively). However, when an inhibitor of lysozyme,N,N,N-
triacetylchitotriose (26), was coinjected with the intact Lys-type
PG, no melanin synthesis could be observed (SI Fig. 8D). In a
control experiment, coinjection of lysozyme inhibitor and par-
tially digested insoluble Lys-type PG induced melanin synthesis
(SI Fig. 8E). These results strongly suggest that prior partial
degradation of Lys-type PG by lysozyme is necessary for acti-
vation of the prophenoloxidase cascade.
To ascertain the role of lysozyme in the recognition of
Lys-type PG by PGRP-SAs in vitro, we examined the binding
abilities of PGRP-SAs to the partially digested Lys-type PGs
using Drosophila PGRP-SA and Tenebrio PGRP-SA. To our
surprise, the partial digestion of Lys-type PG by lysozyme
dramatically increased binding of bothDrosophila PGRP-SA and
Tenebrio PGRP-SA to PG (lane 5 in Fig. 4A and B, respectively).
The enhanced interaction between PGRP-SAs and PG should
result in clustering of PGRP-SAs in PG, leading to the activation
of the Toll and prophenoloxidase pathways. Our study presents
the in vitro biochemical evidence that lysozyme plays a crucial
role in enhancing the access ofDrosophila PGRP-SA or Tenebrio
PGRP-SA to insoluble Lys-type PG in the Toll and proph-
enoloxidase pathways, although the possibility that other pro-
teins showing lysozyme-like activity process PGs for PGRP-SA
binding in vivo cannot be excluded.
During the preparation of this article, a report appeared
showing that Drosophila GNBP1 has lysozyme-like activity that
hydrolyzes loosely cross-linked M. luteus Lys-type PG, but not
highly cross-linked S. aureus Lys-type PG (27). Because the
authors found that GNBP1 has the enzymatic activity, they
proposed that Drosophila GNBP1 presents a processed form of
PG for sensing byDrosophila PGRP-SA. Considering the limited
lysozyme-like activity of GNBP1 and the fact that endogenous
lysozymes in the insect hemolymph is active on highly cross-
linked PGs, GNBP1 may have less importance for processing PG
than the hemolymph lysozyme. However, the limited lysozyme-
like activity of GNBP1 may play an important role in amplifying
or scavenging the recognition signal.
PGRP-SA/PG Complex Recruits GNBP1 and Modular Serine Protease.
We next sought to identify the immediate downstream effec-
tor(s) that recognizes the clustered PGRP-SA molecules on
partially digested Lys-type PGs. To this end, recombinant
Tenebrio PGRP-SA was incubated with the partially digested S.
aureus and M. luteus PGs and then added to the Tenebrio
PGRP-SA-deficient hemolymph solution. Indeed, a 50-kDa
protein (band 1 in Fig. 5A) and a 35-kDa protein (band 2 in Fig.
5A) were specifically enriched on the Tenebrio PGRP-SA-bound,
partially digested Lys-type PGs (lanes 2 and 5 in Fig. 5A), but not
on the Drosophila PGRP-SA/PG complexes (lane 3 in Fig. 5A),
when analyzed by SDS/PAGE. It is notable that the Drosophila
PGRP-SA bound to the partially digested PG did not interact
with the two Tenebrio proteins (lane 3 in Fig. 5A). Also, Tenebrio
PGRP-SA bound to synthetic muropeptide dimer coupled to
Sepharose resin failed to recruit the proteins (lane 7 in Fig. 5A)
under the same conditions, demonstrating that the two proteins
are recruited as a result of clustered PGRP-SA molecules on
Lys-type PG. We identified the two enriched proteins by using
N-terminal amino acid sequencing (see SI Text). The 50-kDa
protein (band 1 in Fig. 5A) was identified as a Tenebrio GNBP1,
and the 35-kDa protein (band 2 in Fig. 5A) is a Tenebriomodular
Fig. 4. The ability of PGRP-SAs to bind to partially digested insoluble PG. (A)
Ability of Drosophila PGRP-SA to bind to the partially digested insoluble
Lys-type PG. Lyso () and Lyso () indicate intact PG without and with
lysozyme (Lyso) treatment, respectively. Lane 1, Drosophila PGRP-SA only;
lanes 2 and 4, the amounts of unbound (U)Drosophila PGRP-SA when Lyso ()
or Lyso () PG was incubated with Drosophila PGRP-SA, respectively; lanes 3
and 5, the amounts of bound (B) Drosophila PGRP-SA on Lys () or Lys () PG,
respectively. (B) Binding ability of Tenebrio PGRP-SA to intact or the partially
digested insoluble PG was examined. The assignment of each lane is the same
as in A.








serine protease, but not containing a clip domain that is com-
monly found in the upstream proteases of the Toll and proph-
enoloxidase cascades (28) (Fig. 5 B–D). GNBP1 was reported to
physically interact with PGRP-SA for the activation of the Toll
pathway in Drosophila (5), but any strong binding of GNBP1 to
PGRP-SA in vitro has not previously been observed. Our ob-
servation supports that clustered binding of PGRP-SA mole-
cules on PG enhances the interaction of PGRP-SA with GNBP1
and that the GNBP1 homologue may also be involved in the
prophenoloxidase pathway. Tenebrio modular serine protease
contains low-density lipoprotein receptor A repeat domains, one
complement control protein domain, and a serine protease
domain. Manduca sexta hemolymph protease 14 (Ms-HP-14),
containing a domain arrangement similar to that of the Tenebrio
modular serine protease, was recently reported as an initiation
enzyme of the prophenoloxidase activation system in M. sexta
that binds curdlan, zymosan, and yeast and also interacts with PG
(29, 30). In this study we present evidence that the modular
serine protease is recruited to an initial activation complex
consisting of the GNBP1 homologue, PGRP-SA, and PG.
Discussion
Gram-negative bacteria are innately resistant to lysozyme be-
cause the LPS layer of the outer membrane protects the inner PG
layer. When Gram-negative bacteria invade insect hemolymph,
the immune deficiency pathway is elicited by recognition of
monomeric and/or polymeric diaminopimelic acid-type PG frag-
ments that are released during cell growth and division. In
contrast, when Gram-positive bacteria invade insect hemo-
lymph, the hemolymph lysozyme is able to digest the exposed
multi-PG layer of Gram-positive bacteria. If the PG layer of the
bacteria is completely degraded by lysozyme, leading to lysis of
the bacteria, the bacteria are not harmful to the insect anymore.
Consistently, the monomeric end products of PG by lysozyme do
Fig. 5. TenebrioGNBP1 protein and modular serine protease are recruited to Tenebrio PGRP-SA-bound partially digested PG. (A) Proteins were extracted from
the intact insoluble PG (lane 1),TenebrioPGRP-SA-bound PG (lane 2), orDrosophilaPGRP-SA-bound PG (lane 3) after incubation withTenebrioPGRP-SA-deficient
hemolymph solution and then analyzed by SDS/PAGE. M. luteus insoluble PG (lanes 4 and 5) and the synthetic muropeptide dimer-coupled resin (lanes 6 and
7) without and withTenebrioPGRP-SA were treated as described inA. It is notable that theDrosophilaPGRP-SA bound to the partially digested PG did not interact
with the two Tenebrio proteins (lane 3). (B) N-terminal amino acid sequence comparison between band 2 and Tribolium castaneum serine protease (Tc-SP,
XP967486), M. sexta hemolymph protease 14 (Ms-HP14) (30), A. gambiae serine protease (Ag-SP, XP321263), and D. melanogaster modular serine protease
(Dm-SP, CG31217). (C) Comparison of the N-terminal sequences of band 1 and T. castaneum GNBP-like protein (Tc-GNBP, XP969449), T. molitor glucan
recognition protein (32) (Tm-GRP), Anopheles gambiae GNBP1 (Ag-GNBP1, AAR13751), and Drosophila melanogaster GNBP1 (Dm-GNBP1) (33). Boxes indicate
residues identical to those in the sequence of band 1. (D) Sequence identities between two internal sequences (Peak 1 and Peak 2) of band 2 and low-density
lipoprotein receptor A repeat domain sequence of Tc-SP.
Fig. 6. A model summarizing the molecular events in the initiation of the Toll and prophenoloxidase pathways. Although a few PGRP-SA (R) molecules bind
to intact PG, it is not able to activate the immune responses (A). PG of Gram-positive bacteria is digested partially (B) or completely (B) by lysozyme. Whereas
the partially digested PG recruits more PGRP-SA molecules binding to the bacterial surface (B), the fully digested PG cannot recruit PGRP-SA on the bacterial
surface leading to lysis of the bacterial cell (B). The clustered PGRP-SA molecules recruit GNBP1 and a modular serine protease (SP) containing low-density
lipoprotein receptor A repeat domains (LDL), resulting in the activation of the modular serine protease (C). Then the activated SP triggers the proteolytic cascade
leading to activation of the Toll and prophenoloxidase (proPO) pathways that produce antimicrobial peptide (AMP) and melanin around the invading bacteria.
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not induce the immune responses of insects, although it is bound
to its receptor molecule, PGRP-SA (Fig. 6B). However, several
Gram-positive bacteria produce a highly modified or cross-
linked PG that is not completely digested by lysozyme (25), and
they could survive in the insect hemolymph without other innate
defense systems (Fig. 6C). Here we found that the partially
digested PG with lysozyme generates a stronger and faster
phenoloxidase activity in vivo and in vitro and recruits a larger
number of PGRP-SAmolecules in vitro compared with the intact
PG. We have shown that clustered PGRP-SA plays a critical role
in inducing the Toll and the prophenoloxidase pathways in vivo
and/or in vitro comparing a linearized PG fragment to the natural
or synthetic dimeric muropeptide. Finally, we found that the
Lys-type PG/PGRP-SA complex recruits GNBP1 and modular
serine protease in the beetle system. We propose that this
Lys-type PG/PGRP-SA/GNBP1/modular serine protease com-
plex is the initial activator that triggers serine protease cascades
in the Toll and prophenoloxidase pathways, where lysozyme
presents a processed form of PG for binding of PGRP-SA,
GNBP1, and modular serine protease (Fig. 6). In conclusion, the
present work provides biochemical data about how the Lys-type
PG recognition signal is transferred downstream.
Materials and Methods
Details of some materials and methods are available in the SI
Text.
Fly Stock and drosomycin Expression. OregonR flies were used as
the wild-type strain. PGRP-SAseml is a line carrying the semmel-
weis mutation (Cys54Tyr) in Drosophila PGRP-SA (3). Ten
nanoliters of water, the linearized PG (10 mgml1), or synthetic
muropeptide dimer (10 mgml1) was injected into the thorax of
the wild-type or PGRP-SAseml female adults (3–4 days old) by
using a Nanoject apparatus (Drummond, Broomall, PA). After
injection, the flies were then incubated for 18 h at 25°C.
drosomycin expression level was measured as previously de-
scribed (31).
Binding Assay of PGRP-SAs to Partially Digested Insoluble PGs. The
binding assay was performed according to the previously re-
ported method (18). Briefly, 10 g of the purified Tenebrio
PGRP-SA or Drosophila PGRP-SA was mixed with 40 l of a
50% (vol/vol) suspension of the partially digested S. aureus orM.
luteus PG (500 g) in 50 mM TrisHCl (pH 7.0) for 12 h at 4°C
in a shaker. Unbound PGRP-SA proteins in the supernatant and
bound PGRP-SAs in the pellet fraction were analyzed by SDS/
PAGE.
Identification of Tenebrio GNBP1 and Associated Modular Serine
Protease. For this experiment, we prepared a Tenebrio PGRP-
SA-deficient hemolymph solution according to the previously
reported method by using the synthetic muropeptide dimer-
coupled affinity column (18). This solution contains all of the
essential components, except for Tenebrio PGRP-SA, necessary
for the activation of the prophenoloxidase system by Lys-type
PG. Tenebrio PGRP-SA (40 g) was incubated with partially
digested insoluble Lys-type PG (8 mg) in 200 l of PBS for 12 h
at 4°C. After incubation, Tenebrio PGRP-SA-bound insoluble
Lys-type PG was recovered by centrifugation at 20,000  g for
10 min at 4°C, washed three times first with 20 mMTrisHCl (pH
8.0) and next with 50 mM TrisHCl (pH 6.0). The recovered
Tenebrio PGRP-SA-bound Lys-type PG was incubated with 2.5
ml of the Tenebrio PGRP-SA-deficient hemolymph solution (20
mg of total protein) for 3 h at 4°C. After removing the insoluble
residue by centrifugation, the mixture was washed twice with 50
mM TrisHCl (pH 6.0). The bound proteins on the insoluble
Lys-type PG were extracted with 100 l of 2 SDS/PAGE
loading buffer and then separated by SDS/PAGE. The protein
bands on the polyacrylamide gel were transferred onto a PVDF
membrane, and then the N-terminal amino acid sequences of the
50-kDa (TenebrioGNBP1) and 35-kDa (Tenebriomodular serine
protease) proteins were determined on an automatic gas-phase
amino acid sequencer (Applied Biosystems, Foster City, CA).
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